Investments
OptiFuel Systems
Accelerating the Pace to Zero-Emissions in Rail, Marine & PowerLink: Meet OptiFuelOptiFuel reimagined locomotive power, integrating the most advanced biofuel engine technology from Cummins to optimize cost, performance, uptime, and fuel economy – with zero emissions. The company then transformed 200-year-old manufacturing practices; engineering novel modularity to make customization, reconfiguration, fuel flexibility, and on-rail maintenance possible.
Helix Semiconductors
Transformerless PowerInvestment Year: 2022Imagine a laptop charger so small it fits right into your pocket. Imagine a military drone that can’t be picked up by heat sensing technology because it emits virtually no heat. Sound impossible? It was – until Helix Semiconductors developed the game-changing technology that made both a reality. Helix' patented, transformer-less power supply technology is transforming power as we know it.
Cantera Negra Tequila
Award-Winning TequilaInvestment Year: 2021SIGNIFICANT TRANSACTIONS:11.2022. Deutsch Family Wine & Spirits acquires 25% stake in Cantera Negra.This transaction connects Cantera Negra to some of the most sophisticated marketing and operations prowess in the industry. Deutsch Family Wine & Spirits has a phenomenal record of growing brands. Their partnership with Casella in 2001 rocketed the Yellow Tail brand to 1.2 million cases. Ten years later, in 2011, they repeated this success with Josh Cellars - taking the brand from 25,000 cases to 150,000 cases in single year.
Open Therapeutics
Open Science for Collaboration that Changes LivesInvestment Year: 2020Research institutions hold a massive amount of shelved research. Open Therapeutics enables the scientific community to source & connect existing research with new research - protecting each scientists credits and rights while enabling collaboration and compensation. Most research fields have an interdisciplinary impact on human, plant, animal, and planetary health. Therapoid seeks to enable positive scientific impact on health outcomes by providing an open science environment controlled by the research community. Open Therapeutics is a B Corp that serves as custodian of the largest scientific thinktank in the world.
